Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Vyne Therapeutics Inc (VYNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2018	03-2018	12-2017	09-2017	06-2017
Assets
Current Assets
Cash & Cash Equivalents	73,584	78,527	10,206	0	0
Marketable Securities	80,171	77,310	49,295	0	0
Receivables	93	234	786	0	0
TOTAL	$156,163	$159,658	$63,861	$0	$0

Non-Current Assets
PPE Net	22	25	28	N/A	N/A
Investments And Advances	10,425	20,713	2,978	0	0
Other Non-Current Assets	306	83	0	0	0
TOTAL	$10,753	$20,821	$3,006	$N/A	$N/A

Total Assets	$166,916	$180,479	$66,867	$0	$0

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	5,089	3,501	2,462	0	0
Accrued Expenses	3,560	3,174	3,559	0	0
TOTAL	$8,649	$8,471	$7,817	$0	$0

Non-Current Liabilities
Deferred Revenues	0	1,796	1,796	N/A	N/A
Other Non-Current Liabilities	78	20	22	0	0
TOTAL	$78	$6,306	$6,757	$N/A	$N/A

Total Liabilities	$8,727	$14,777	$14,574	$0	$0

Shareholders' Equity
Shares Outstanding, K	319	319	N/A	N/A	N/A
Common Shares	3	3	1	0	0
Retained earnings	-80,194	-71,848	-59,191	0	0
Other shareholders' equity	-150	-202	109,276	0	0
TOTAL	$158,189	$165,702	$52,293	$0	$0

Total Liabilities And Equity	$166,916	$180,479	$66,867	$0	$0